Vertex Pharmaceuticals Incorporated shares owned by Motley Fool Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Motley Fool Asset Management
from 13F filings
Historical chart of Motley Fool Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Motley Fool Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Motley Fool Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.9M | 18k | 391.64 |
| 2025-06-30 | $7.0M | 16k | 445.20 |
| 2025-03-31 | $6.7M | 14k | 484.82 |
| 2024-12-31 | $5.4M | 14k | 402.70 |
| 2024-09-30 | $5.5M | 12k | 469.76 |
| 2024-06-30 | $5.2M | 11k | 471.25 |
| 2024-03-31 | $14M | 34k | 418.01 |
| 2023-12-31 | $3.1M | 7.6k | 406.89 |
| 2023-09-30 | $2.5M | 7.2k | 347.74 |
| 2023-06-30 | $2.3M | 6.6k | 351.91 |
| 2022-12-31 | $1.8M | 6.3k | 288.78 |
| 2022-09-30 | $1.9M | 6.5k | 289.54 |
| 2022-06-30 | $1.9M | 6.5k | 288.99 |
| 2022-03-31 | $1.8M | 6.8k | 261.02 |
| 2021-12-31 | $1.4M | 6.6k | 219.58 |
| 2021-09-30 | $1.2M | 6.5k | 181.43 |
| 2021-06-30 | $1.2M | 6.2k | 201.56 |
| 2021-03-31 | $1.3M | 6.0k | 214.86 |
| 2020-12-31 | $1.4M | 6.1k | 236.34 |
| 2020-09-30 | $1.5M | 5.6k | 273.56 |
| 2020-06-30 | $1.4M | 4.9k | 290.30 |
| 2020-03-31 | $1.0M | 4.3k | 237.90 |
| 2019-12-31 | $1.0M | 4.6k | 218.89 |
| 2019-09-30 | $786k | 4.6k | 169.51 |
| 2019-06-30 | $784k | 4.3k | 183.39 |
| 2019-03-31 | $727k | 4.0k | 183.91 |
| 2018-12-31 | $514k | 3.1k | 165.86 |
| 2018-09-30 | $541k | 2.8k | 192.87 |
| 2018-06-30 | $455k | 2.7k | 170.09 |
| 2018-03-31 | $368k | 2.3k | 163.19 |
More positions owned by Motley Fool Asset Management
View all positions for Motley Fool Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated